The presence of antiphospholipid antibodies (aPL) combined with venous or arterial
thrombosis, and/or obstetric complications defines the antiphospholipid syndrome (APS) …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …

The diagnosis of antiphospholipid syndrome (APS) requires the presence of both clinical
and biological features. Due to the heterogeneity of anti-phospholipid antibodies (aPL) the …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and/or obstetrical manifestations and the persistent presence, at least 12 weeks …

Antiphospholipid antibodies (aPL) constitute a heterogeneous group of autoantibodies that
share the ability to bind phospholipids (PL) alone, protein-PL complexes, or PL-binding …

The clinical hallmarks of the antiphospholipid syndrome (APS) were described in the early
1980s as vascular thrombosis and pregnancy morbidity. Some of these events, such as …

Antiphospholipid antibodies (aPL) are an heterogeneous group of circulating
immunoglobulins arising in a wide range of infectious and autoimmune diseases. Since the …

While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β 2 glycoprotein I (anti-
β 2 GPI) antibodies represent the best available and the most widely used tests in the …

The international classification criteria for definite antiphospholipid syndrome (APS) include
three laboratory measurements: lupus anticoagulant (LA), IgG and IgM isotypes of anti …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent
vascular thrombosis (VT) and/or pregnancy morbidity (PM) in the presence of persistent …